Induction of ICER is superseded by smICER, challenging the impact of ICER under chronic beta-adrenergic stimulation.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
08 2020
Historique:
received: 11 09 2019
revised: 30 03 2020
accepted: 21 04 2020
pubmed: 1 7 2020
medline: 26 2 2021
entrez: 1 7 2020
Statut: ppublish

Résumé

ICER (inducible cAMP early repressor) isoforms are transcriptional repressors encoded by the Crem (cAMP responsive element modulator) gene. They were linked to the regulation of a multitude of cellular processes and pathophysiological mechanisms. Here, we show for the first time that two independent induction patterns for CREM repressor isoforms exist in the heart, namely for ICER and smICER (small ICER), which are induced in response to β-adrenergic stimulation in a transient- and saturation-like manner, respectively. This time-shifted induction pattern, driven by two internal promoters in the Crem gene, leads to the predominant transcription of smIcer after prolonged β-adrenergic stimulation. Using an ICER knockout mouse model with preserved smICER induction, we show that the transient-like induction of Icer itself has minor effects on gene regulation, cardiac hypertrophy or contractile function in the heart. We conclude that the functions previously linked to ICER may be rather attributed to smICER, also beyond the cardiac background.

Identifiants

pubmed: 32602979
doi: 10.1096/fj.201902301RR
doi:

Substances chimiques

Adrenergic beta-Agonists 0
Crem protein, mouse 0
Receptors, Adrenergic, beta 0
Cyclic AMP Response Element Modulator 135844-64-3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11272-11291

Informations de copyright

© 2020 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.

Références

MayrB, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001;2:599-609.
Sassone-CorsiP. Transcription factors responsive to cAMP. Annu Rev Cell Dev Biol. 1995;11:355-377.
DelmasV, Laoide BM, Masquilier D, de Groot RP, Foulkes NS, Sassone-Corsi P. Alternative usage of initiation codons in mRNA encoding the cAMP-responsive-element modulator generates regulators with opposite functions. Proc Natl Acad Sci USA. 1992;89:4226-4230.
FoulkesNS, Borrelli E, Sassone-Corsi P. CREM gene: use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Cell. 1991;64:739-749.
GellersenB, Kempf R, Sandhowe R, Weinbauer GF, Behr R. Novel leader exons of the cyclic adenosine 3′,5′-monophosphate response element modulator (CREM) gene, transcribed from promoters P3 and P4, are highly testis-specific in primates. Mol. Hum. Reprod. 2002;8:965-976.
SeidlMD, Nunes F, Fels B, et al. A novel intronic promoter of the Crem gene induces small ICER (smICER) isoforms. FASEB J. 2014;28:143-152.
RauenT, Benedyk K, Juang Y-T, et al. A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus. J Biol Chem. 2011;286:32366-32372.
DanielPB, Rohrbach L, Habener JF. Novel cyclic adenosine 3′,5′-monophosphate (cAMP) response element modulator theta isoforms expressed by two newly identified cAMP-responsive promoters active in the testis. Endocrinology. 2000;141:3923-3930.
JaspersS, Gellersen B, Kempf R, Samalecos A, Bergmann M, Steger K. Functional characterization of male germ cell-specific CREM isoforms. J Androl. 2007;28:59-66.
DonJ, Stelzer G. The expanding family of CREB/CREM transcription factors that are involved with spermatogenesis. Mol Cell Endocrinol. 2002;187:115-124.
NervinaJM, Tetradis S, Huang Y-F, Harrison D, Molina C, Kream BE. Expression of inducible cAMP early repressor is coupled to the cAMP-protein kinase A signaling pathway in osteoblasts. Bone. 2003;32:483-490.
VaethM, Gogishvili T, Bopp T, et al., Regulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1). Proc Nat Acad Sci. 2011;108(6):2480-2485. https://doi.org/10.1073/pnas.1009463108
BorlikovaG, Endo S. Inducible cAMP early repressor (ICER) and brain functions. Mol Neurobiol. 2009;40:73-86.
KojimaN, Borlikova G, Sakamoto T, et al. Inducible cAMP early repressor acts as a negative regulator for kindling epileptogenesis and long-term fear memory. J Neurosci. 2008;28:6459-6472.
GreenTA, Alibhai IN, Hommel JD, et al. Induction of inducible cAMP early repressor expression in nucleus accumbens by stress or amphetamine increases behavioral responses to emotional stimuli. J Neurosci. 2006;26:8235-8242.
FavreD, Niederhauser G, Fahmi D, et al. Role for inducible cAMP early repressor in promoting pancreatic beta cell dysfunction evoked by oxidative stress in human and rat islets. Diabetologia. 2011;54:2337-2346.
InadaA, Hamamoto Y, Tsuura Y, et al. Overexpression of inducible cyclic AMP early repressor inhibits transactivation of genes and cell proliferation in pancreatic beta cells. Mol Cell Biol. 2004;24:2831-2841.
MolinaCA, Foulkes NS, Lalli E, Sassone-Corsi P. Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. An alternative promoter directs the expression of ICER, an early response repressor. Cell. 1993;75:875-886.
BieganskaK, Figiel I, Gierej D, Kaczmarek L, Klejman A. Silencing of ICERs (inducible cAMP early repressors) results in partial protection of neurons from programmed cell death. Neurobiol Dis. 2012;45:701-710.
TomitaH, Nazmy M, Kajimoto K, Yehia G, Molina CA, Sadoshima J. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation. Circ Res. 2003;93:12-22.
DingB, Abe J-I, Wei H, et al. A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis. Proc Natl Acad Sci USA. 2005;102:14771-14776.
YanC, Ding B, Shishido T, et al. Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop. Circ Res. 2007;100:510-519.
MaD, Fu L, Shen J, et al. Interventional effect of valsartan on expression of inducible cAMP early repressor and phosphodiesterase 3A in rats after myocardial infarction. Eur J Pharmacol. 2009;602:348-354.
YanC, Miller CL, Abe J-I. Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart. Circ Res. 2007;100:489-501.
MyersR, Timofeyev V, Li N, et al. Feedback mechanisms for cardiac-specific microRNAs and cAMP signaling in electrical remodeling. Circulation. 2015;8:942-950.
MüllerFU, Bokník P, Knapp J, et al. Identification and expression of a novel isoform of cAMP response element modulator in the human heart. FASEB J. 1998;12:1191-1199.
MüllerFU, Lewin G, Baba HA, et al. Heart-directed expression of a human cardiac isoform of cAMP-response element modulator in transgenic mice. J Biol Chem. 2005;280:6906-6914.
SeidlMD, Stein J, Hamer S, et al. Characterization of the genetic program linked to the development of atrial fibrillation in CREM-IbΔC-X mice. Circulation. 2017;10(8). https://doi.org/10.1161/CIRCEP.117.005075.
SchulteJS, Fehrmann E, Tekook MA, et al. Cardiac expression of the CREM repressor isoform CREM-IbΔC-X in mice leads to arrhythmogenic alterations in ventricular cardiomyocytes. Basic Res Cardiol. 2016;111:15.
HeinickA, Husser X, Himmler K, et al. Annexin A4 is a novel direct regulator of adenylyl cyclase type 5. FASEB J. 2015;29:3773-3787.
BradfordMM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
BolgerAM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics (Oxford, England). 2014;30:2114-2120.
KimD, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12:357-360.
LiH. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics (Oxford, England). 2011;27:2987-2993.
AndersS, Pyl PT, Huber W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics (Oxford, England). 2015;31:166-169.
LoveMI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
ThorvaldsdóttirH, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14:178-192.
QuinlanAR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics (Oxford, England). 2010;26:841-842.
HuangW, Loganantharaj R, Schroeder B, Fargo D, Li L. PAVIS: a tool for peak annotation and visualization. Bioinformatics (Oxford, England). 2013;29:3097-3099.
FengJ, Liu T, Qin B, Zhang Y, Liu XS. Identifying ChIP-seq enrichment using MACS. Nat Protoc. 2012;7:1728-1740.
HulsenT, de Vlieg J, Alkema W. BioVenn-a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genom. 2008;9:488.
BehrR, Weinbauer GF. CREM activator and repressor isoforms in human testis: sequence variations and inaccurate splicing during impaired spermatogenesis. sequence variations and inaccurate splicing during impaired spermatogenesis. Mol Hum Reprod. 2000;6:967-972.
MonacoL, Kotaja N, Fienga G, et al. Specialized rules of gene transcription in male germ cells: the CREM paradigm. Int J Androl. 2004;27:322-327.
KosirR, Juvan P, Perse M, et al. Novel insights into the downstream pathways and targets controlled by transcription factors CREM in the testis. PLoS ONE. 2012;7:e31798.
RauenT, Hedrich CM, Tenbrock K, Tsokos GC. cAMP responsive element modulator: a critical regulator of cytokine production. Trends Mol Med. 2013;19:262-269.
XuW-D, Zhang Y-J, Wang W, Li R, Pan H-F, Ye D-Q. Role of CREM in systemic lupus erythematosus. Cell Immunol. 2012;276:10-15.
ChiappiniF, Ramadoss P, Vella KR, et al. Family members CREB and CREM control thyrotropin-releasing hormone (TRH) expression in the hypothalamus. Mol Cell Endocrinol. 2013;365:84-94.
MioduszewskaB, Jaworski J, Kaczmarek L. Inducible cAMP early repressor (ICER) in the nervous system-a transcriptional regulator of neuronal plasticity and programmed cell death. J Neurochem. 2003;87:1313-1320.
FolcoEJ, Koren G. Degradation of the inducible cAMP early repressor (ICER) by the ubiquitin-proteasome pathway. Biochem J. 1997;328(Pt 1):37-43.
DingB, Abe J-I, Wei H, et al. Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure. implication in heart failure. Circulation. 2005;111:2469-2476.
XiangH, Wang J, Boxer LM. Role of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B cells. Mol Cell Biol. 2006;26:8599-8606.
CatzSD, Johnson JL. Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene. 2001;20:7342-7351.
MartianovI, Choukrallah M-A, Krebs A, et al. Cell-specific occupancy of an extended repertoire of CREM and CREB binding loci in male germ cells. BMC Genom. 2010;11:530.
GellersenB, Kempf R, Telgmann R. Human endometrial stromal cells express novel isoforms of the transcriptional modulator CREM and up-regulate ICER in the course of decidualization. Mol. Endocrinol. 1997;11:97-113.

Auteurs

Matthias D Seidl (MD)

Institute of Pharmacology and Toxicology, University of Münster, Münster, Germany.

Benedikt Fels (B)

Institute of Pharmacology and Toxicology, University of Münster, Münster, Germany.

Daniel Kranick (D)

Institute of Pharmacology and Toxicology, University of Münster, Münster, Germany.

Alexandra Sternberg (A)

Institute of Pharmacology and Toxicology, University of Münster, Münster, Germany.

Kristina Grimm (K)

Institute of Pharmacology and Toxicology, University of Münster, Münster, Germany.

Frank T Stümpel (FT)

Institute of Pharmacology and Toxicology, University of Münster, Münster, Germany.

Florentina Pluteanu (F)

Institute of Pharmacology and Toxicology, University of Münster, Münster, Germany.

Jan S Schulte (JS)

Institute of Pharmacology and Toxicology, University of Münster, Münster, Germany.

Alexander Heinick (A)

Institute of Pharmacology and Toxicology, University of Münster, Münster, Germany.

Nobuhiko Kojima (N)

Faculty of Life Sciences, Toyo University, Gunma, Japan.

Shogo Endo (S)

Aging Neuroscience Research Team, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.

Andreas Huge (A)

Core Facility Genomik, Medical Faculty, University of Muenster, Germany.

Monika Stoll (M)

Core Facility Genomik, Medical Faculty, University of Muenster, Germany.

Frank U Müller (FU)

Institute of Pharmacology and Toxicology, University of Münster, Münster, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH